Acute Myeloid Leukemia Clinical Trial
Quality of Life Model for Older Patients With AML
The purpose of this study is to describe the differences in quality of life (QOL) among newly diagnosed patients diagnosed with acute myeloid leukemia (AML) to help design a patient decision-making QOL model for aligning patients' choice of treatment with what matters the most to them.
60 years of age or older
Newly diagnosed with pathology-confirmed diagnosis of Acute Myeloid Leukemia
Within 7 days of starting a new treatment
Must be able to read and speak English at the 8th grade level
Under 60 years of age
Other malignancy, dementia, traumatic brain injury or individuals with central nervous system involvement of their leukemia
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Tampa Florida, 33612, United States
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.